Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1090

1.

Promoting neurotrophic effects by GPCR ligands.

Jeanneteau F, Chao MV.

Novartis Found Symp. 2006;276:181-9; discussion 189-92, 233-7, 275-81. Review.

PMID:
16805430
2.
3.

Activation of Trk neurotrophin receptors in the absence of neurotrophins.

Lee FS, Chao MV.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3555-60. Epub 2001 Mar 6.

4.

Neurotrophins and their receptors in nerve injury and repair.

Ebadi M, Bashir RM, Heidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi MD, Cerutis DR, Lassi NK.

Neurochem Int. 1997 Apr-May;30(4-5):347-74. Review.

PMID:
9106250
5.

Distinctive features of Trk neurotrophin receptor transactivation by G protein-coupled receptors.

Lee FS, Rajagopal R, Chao MV.

Cytokine Growth Factor Rev. 2002 Feb;13(1):11-7. Review.

PMID:
11750876
6.

The Trk family of neurotrophin receptors.

Barbacid M.

J Neurobiol. 1994 Nov;25(11):1386-403. Review.

PMID:
7852993
7.

GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation.

Delcourt N, Bockaert J, Marin P.

Trends Pharmacol Sci. 2007 Dec;28(12):602-7. Epub 2007 Nov 14. Review.

PMID:
18001849
8.

Rational basis for Trk inhibition therapy for prostate cancer.

Weeraratna AT, Arnold JT, George DJ, DeMarzo A, Isaacs JT.

Prostate. 2000 Oct 1;45(2):140-8.

PMID:
11027413
9.

The neuropeptide pituitary adenylate cyclase activating protein stimulates human monocytes by transactivation of the Trk/NGF pathway.

El Zein N, Badran BM, Sariban E.

Cell Signal. 2007 Jan;19(1):152-62. Epub 2006 Jun 7.

PMID:
16914291
10.

Neurotrophin receptor structure and interactions.

Yano H, Chao MV.

Pharm Acta Helv. 2000 Mar;74(2-3):253-60. Review.

PMID:
10812966
11.

Differential dependency of unmyelinated and A delta epidermal and upper dermal innervation on neurotrophins, trk receptors, and p75LNGFR.

Rice FL, Albers KM, Davis BM, Silos-Santiago I, Wilkinson GA, LeMaster AM, Ernfors P, Smeyne RJ, Aldskogius H, Phillips HS, Barbacid M, DeChiara TM, Yancopoulos GD, Dunne CE, Fundin BT.

Dev Biol. 1998 Jun 1;198(1):57-81.

12.

Overcoming the inhibitors of myelin with a novel neurotrophin strategy.

Williams G, Williams EJ, Maison P, Pangalos MN, Walsh FS, Doherty P.

J Biol Chem. 2005 Feb 18;280(7):5862-9. Epub 2004 Nov 30.

13.

[Neurotrophins. I: Molecular features].

Zazpe A, Del Río J.

Rev Med Univ Navarra. 1997 Jul-Sep;41(3):173-9. Review. Spanish.

PMID:
10420923
14.

p75 Co-receptors regulate ligand-dependent and ligand-independent Trk receptor activation, in part by altering Trk docking subdomains.

Zaccaro MC, Ivanisevic L, Perez P, Meakin SO, Saragovi HU.

J Biol Chem. 2001 Aug 17;276(33):31023-9. Epub 2001 Jun 25.

16.

Gangliosides activate Trk receptors by inducing the release of neurotrophins.

Rabin SJ, Bachis A, Mocchetti I.

J Biol Chem. 2002 Dec 20;277(51):49466-72. Epub 2002 Oct 17.

17.

PACAP promotes sensory neuron differentiation: blockade by neurotrophic factors.

Nielsen KM, Chaverra M, Hapner SJ, Nelson BR, Todd V, Zigmond RE, Lefcort F.

Mol Cell Neurosci. 2004 Apr;25(4):629-41.

PMID:
15080892
18.

Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.

Sugimoto T, Kuroda H, Horii Y, Moritake H, Tanaka T, Hattori S.

Jpn J Cancer Res. 2001 Feb;92(2):152-60.

PMID:
11223544
19.

Neurotrophin signalling in health and disease.

Chao MV, Rajagopal R, Lee FS.

Clin Sci (Lond). 2006 Feb;110(2):167-73. Review.

PMID:
16411893
20.

Supplemental Content

Support Center